At a glance
ClinicalIndex Comparison RecordN/ACompleted· 14 enrolled
Drug / intervention
BTE hearing aiddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Validation of 2 Novel BTE Hearing Aid Models Varying With Respect to Regular-power or Super-power Gain Specifications
In Brief
A clinical study evaluating BTE hearing aid for Hearing Loss. Completed, enrolled 14 participants across 1 site.
Detailed Summary
Participants will wear one set of 2 different BTE hearing aid models based on the gain required by their hearing loss. The hearing aids will be programmed based on a prescriptive approach and participants will be sent out for either one home trial with the less powerful BTEs or for two home trials with the SP (super power) BTEs.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesCanada
CollaboratorsSonova Canada Inc.
Timeline
N/ACompletedFinished
20222023202420252026
First PostedMay 2021
Enrollment StartMay 2021
Primary CompletionJul 2021
TodayJul 2026
First PostedMay 12, 2021
Enrollment StartMay 14, 2021
Primary CompletionJul 13, 2021
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.1 years ago
Interventions
BTE hearing aiddevice
Amplification